The latest in pancreatic cancer research: Lustgarten Foundation awardees present their findings.
Wilentz
R E
RE
Department of Pathology, The Johns Hopkins University School of Medicine, USA.
D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors; D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use; D002869:Chromosome Aberrations; D003713:Dendritic Cells / Q000276:immunology; D051231:Farnesyltranstransferase; D006801:Humans; D051379:Mice; D009569:Nitric Oxide / Q000096:biosynthesis; D010190:Pancreatic Neoplasms / Q000235:genetics / Q000628:therapy*; D017346:Protein Serine-Threonine Kinases; D012334:RNA, Neoplasm / Q000627:therapeutic use; D000077294:Receptor, Transforming Growth Factor-beta Type II; D018125:Receptors, Transforming Growth Factor beta / Q000235:genetics
D019496:Cancer Vaccines; D012334:RNA, Neoplasm; D018125:Receptors, Transforming Growth Factor beta; D009569:Nitric Oxide; D019883:Alkyl and Aryl Transferases; D051231:Farnesyltranstransferase; D017346:Protein Serine-Threonine Kinases; D000077294:Receptor, Transforming Growth Factor-beta Type II